LABIXIAOXIN issues 20.83 million new shares, lifting outstanding share count by 9.5 % in March

Bulletin Express
Apr 01

Labixiaoxin Snacks Group Limited (LABIXIAOXIN) reported that, for the month ended 31 March 2026, its issued share base rose by 20.83 million ordinary shares—or 9.5 %—to 239.25 million shares.

The increase stemmed from a consideration issue completed on 31 March 2026, previously authorised at the company’s 19 June 2025 general meeting. The new shares were allotted at HKD 3.98 each.

Authorised share capital remained unchanged at 500 million ordinary shares with a par value of HKD 0.001, representing total authorised capital of HKD 0.50 million. No treasury shares were held before or after the transaction, and no share repurchases or cancellations were recorded during the month.

Following the issuance, LABIXIAOXIN confirmed compliance with the Hong Kong Stock Exchange’s minimum 25 % public-float requirement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10